ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Journal and News Scan

Source: The New England Journal of Medicine
Author(s): Fatima Rodriguez MD, MPH and Robert A Harrington MD

This review nicely summarizes the recommendations for antithrombotic therapy in the setting of acute coronary syndromes.  In a section relevant to cardiac surgeons, they suggest that patients who undergo CABG surgery in the setting of an acute coronary syndrome should be similarly treated with dual antiplatelet therapy.

Source: European Journal of Cardio-Thoracic Surgery
Author(s): Silvia Mas-Peiro, Gloria Faerber, Dimitra Bon, Eva Herrmann, Timm Bauer, Sabine Bleiziffer, Raffi Bekeredjian, Andreas Böning, Christian Frerker, Andreas Beckmann, Helge Möllmann, Mariuca Vasa-Nicotera, Stephan Ensminger, Christian W Hamm, Friedhelm Beyersdorf, Stephan Fichtlscherer, Thomas Walther for the GARY-Executive Board
This analysis presents the impact of chronic kidney disease on patients undergoing TAVI or SAVR procedures.
Source: The Annals of Thoracic Surgery
Author(s): Erin M. Corsini, MD, MSc, Nicolas Zhou, DO, Mara B. Antonoff, MD, Reza J. Mehran, MD, David C. Rice, MD, Jack A. Roth, MD, Boris Sepesi, MD, Stephen G. Swisher, MD, Ara A. Vaporciyan, MD, Garrett L. Walsh, MD, and Wayne L. Hofstetter, MD
This study analyzes the medication Ketorolac when used for acute kidney injury or bleeding after surgery.
Source: FDA NEWS RELEASE
Author(s): U.S. Food and Drug Administration

On Friday, March 26, the U.S. Food and Drug Administration approved the Harmony Transcatheter Pulmonary Valve (TPV) System to be used to treat pediatric and adult patients with a native or surgically-repaired right ventricular outflow tract who have severe pulmonary valve regurgitation. 

Source: The Annals of Thoracic Surgery
Author(s): Norma E. Farrow, MD, MHS, Vignesh Raman, MD, MHS, Oliver K. Jawitz, MD, MHS,Soraya L. Voigt, MD, Betty C. Tong, MD, MHS, David H. Harpole, Jr, MD, and Thomas A. D’Amico, MD

This study analyzes surgery versus chemoradiation for esophageal cancer in older patients.

Source: European Journal of Cardio-Thoracic Surgery
Author(s): Anders Holmgren, Tone Bull Enger, Ulf Näslund, Vibeke Videm, Solveig Valle, Karen Julie Dybvad Evjemo, Örjan Friberg, Alexander Wahba

Holmgren et al. report the long-term outcome of aortic valve replacement patients for bicuspid or tricuspid aortic valve pathologies within a Swedish cohort. In their analysis, patients with bicuspid valve morphology showed an independent association with improved outcome, even matching the general population´s prognosis.

Source: European Journal of Cardio-Thoracic Surgery
Author(s): Ahmadali Amirghofran, Fatemeh Edraki, Mohammadreza Edraki, Gholamhossein Ajami, Hamid Amoozgar, Hamid Mohammadi, Abbas Emaminia, Bahram Ghasemzadeh, Mohammad Borzuee, Farah Peiravian, Zahra Kheirandish, Nima Mehdizadegan, Mohammadreza Sabri, Sirus Cheriki, Hamid Arabi

Amirghofran et al. present a cohort of 21 patients receiving repair of tetralogy of Fallot (ToF) by a new surgical technique using autologous right atrial appendage tissue as a pulmonary valve substitute. This technique was proven feasible with good mid-term results and valve function in patients undergoing ToF repair requiring a PA valve substitute.

Source: The Annals of Thoracic Surgery
Author(s): Zaid M. Abdelsattar, MD, MS, Mohamed F. Elsisy, MB, BCh, Hartzell Schaff, MD, John Stulak, MD, Kevin Greason, MD, Alberto Pochettino, MD, Arman Arghami, MD, Philip Rowse, MD, Gabor Bagameri, MD, Vishal Khullar, MD, Richard Daly, MD, Sertac Cicek, MD, Joseph Dearani, MD, and Juan Crestanello, MD

This study compared outcomes of mechanical valves, bioprostheses, and homografts patients undergoing an operation for active complex aortic endocarditis.

Source: World Journal for Pediatric and Congenital Heart Surgery
Author(s): Marshall L. Jacobs, MD, Jeffrey P. Jacobs, MD, Dylan Thibault, MS, Kevin D. Hill, MD, MS, Brett R. Anderson, MD, MBA, MS, Pirooz Eghtesady, MD, PhD, Tara Karamlou, MD, MSc, S. Ram Kumar, MD, PhD, John E. Mayer, MD, Carlos M. Mery, MD, MPH, Meena Nathan, MD, David M. Overman, MD, Sara K. Pasquali, MD, MHS, James D. St. Louis, MD, David Shahian, MD, Sean M. O’Brien, PhD

STAT Mortality Categories (developed 2009) stratify congenital heart surgery procedures into groups of increasing mortality risk to characterize case mix of congenital heart surgery providers. This update of the STAT Mortality Score and Categories is empirically based for all procedures and reflects contemporary outcomes. Cardiovascular surgical operations in the Society of Thoracic Surgeons Congenital Heart Surgery Database (January 1, 2010 – June 30, 2017) were analyzed. In this STAT 2020 Update of the STAT Mortality Score and Categories, the risk associated with a specific combination of procedures was estimated under the assumption that risk is determined by the highest risk individual component procedure. Operations composed of multiple component procedures were eligible for unique STAT Scores when the statistically estimated mortality risk differed from that of the highest risk component procedure. Bayesian modeling accounted for small denominators.

Source: Journal of Thoracic and Cardiovascular Surgery
Author(s): Peter J. Altshuler, Pavan Atluri

A brief editorial with a clear message on the importance of genomics in tailoring aortic surgery to individual patients' long-term outlook.in bicuspid aortic valve disease in the absence of arch dilatation 

Pages